Literature DB >> 20842732

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.

Zofia Hélias-Rodzewicz1, Gaëlle Pérot, Frédéric Chibon, Céline Ferreira, Pauline Lagarde, Philippe Terrier, Jean-Michel Coindre, Alain Aurias.   

Abstract

In a series of 404 adult soft tissue sarcomas, analyzed by array-CGH, we have observed in approximately 10% of them a genomic amplification of either chromosome bands 11q22 or 3p12. These two amplicons likely target the YAP1 and VGLL3 genes, respectively. Both genes encode proteins that are cofactors of the TEAD family of transcription factors. Very good correlations between amplification and expression levels were observed. Welch test analyses of transcriptome data demonstrate that tumors with amplicons share a large set of upregulated and downregulated genes. Inhibition of YAP1 and VGLL3 in cell lines with these amplifications/overexpressions leads to similar phenotypes: decrease of proliferation rate, and to a lesser extent decrease of migration properties. These data, and the fact that these amplicons are observed either in de-differentiated liposarcomas or in undifferentiated pleomorphic sarcomas, suggest that these genetics events could be involved in oncogenesis and progression of soft tissue sarcomas.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842732     DOI: 10.1002/gcc.20825

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  46 in total

Review 1.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

2.  miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.

Authors:  Nan Li; Nanrong Yu; Jia Wang; Haofeng Xi; Weiqun Lu; Houwei Xu; Min Deng; Guopei Zheng; Haiying Liu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Authors:  Wenjing Zhang; Yijun Gao; Peixue Li; Zhubing Shi; Tong Guo; Fei Li; Xiangkun Han; Yan Feng; Chao Zheng; Zuoyun Wang; Fuming Li; Haiquan Chen; Zhaocai Zhou; Lei Zhang; Hongbin Ji
Journal:  Cell Res       Date:  2014-01-24       Impact factor: 25.617

4.  Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Authors:  Cristina R Antonescu; Lei Zhang; G Petur Nielsen; Andrew E Rosenberg; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-06-29       Impact factor: 5.006

Review 5.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

6.  Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.

Authors:  Yu-Chien Kao; Valentina Ranucci; Lei Zhang; Yun-Shao Sung; Edward A Athanasian; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-11       Impact factor: 6.394

7.  Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.

Authors:  Naoto Hori; Kazuyuki Okada; Yuki Takakura; Hiroyuki Takano; Naoto Yamaguchi; Noritaka Yamaguchi
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

Review 8.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

9.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

10.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.